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ABSTRACT
Background and purpose Small vessel disease
(mainly hypertensive arteriopathy and cerebral amyloid
angiopathy (CAA)) is an important cause of spontaneous
intracerebral haemorrhage (ICH), a devastating and still
poorly understood stroke type. Enlarged perivascular
spaces (EPVS) are a promising neuroimaging marker of
small vessel disease. Based on the underlying
arteriopathy distributions, we hypothesised that severe
centrum semiovale EPVS are more common in lobar ICH
attributed to CAA than other ICH. We evaluated EPVS
prevalence, severity and distribution, and their clinical–
radiological associations.
Methods Retrospective multicentre cohort study of 121
ICH patients. Clinical information was obtained using
standardised forms. Basal ganglia and centrum
semiovale EPVS on T2-weighted MRI (graded 0–4 (>40
EPVS)), white-matter changes, cerebral microbleeds
(CMBs) and lacunes were rated using validated scales.
Results Patients with probable or possible CAA (n=76)
had a higher prevalence of severe (>40) centrum semiovale
EPVS compared with other ICH patients (35.5% vs 17.8%;
p=0.041). In logistic regression age (OR: 1.43; 95%
CI 1.01 to 2.02; p=0.045), deep CMBs (OR: 3.27; 95%
CI 1.27 to 8.45; p=0.014) and mean white-matter
changes score (OR: 1.29; 95% CI 1.17 to 1.43;
p<0.0001) were independently associated with increased
basal ganglia EPVS severity; only age was associated with
increased centrum semiovale EPVS severity (OR: 1.50; 95%
CI 1.08 to 2.10; p=0.017).
Conclusions EPVS are common in ICH. Different
mechanisms may account for EPVS according to their
anatomical distribution. Severe centrum semiovale EPVS
may be secondary to, and indicative of, CAA with value as
a new neuroimaging marker. By contrast, basal ganglia
EPVS severity is associated with markers of hypertensive
arteriopathy.
INTRODUCTION
Spontaneous (non-traumatic) intracerebral haemor-
rhage (ICH) is usually deﬁned as ICH not due to
any structural, vascular or other primary cause (eg,
tumour, arteriovenous malformation, aneurysm,
cavernoma), and therefore attributed to intrinsic
disease of the cerebral small vessels. Spontaneous
ICH accounts for more than 75% of ICH in adults,
leading to high rates of death and disability.1 It
results from the rupture of small arteries damaged
by two main age-related cerebral small vessel
diseases: hypertensive arteriopathy (including arter-
iolosclerosis) and cerebral amyloid angiopathy
(CAA). Hypertensive arteriopathy typically affects
the small perforating end-arteries of the deep grey
nuclei and deep white matter, and is an important
cause of ICH in deep structures. CAA is charac-
terised by the progressive deposition of amyloid-β
in the walls of small vessels in the cerebral cortex,
overlying leptomeninges and grey- white-matter
junction, and is a major cause of lobar ICH in the
elderly.2 There is an urgent need to better under-
stand the pathophysiology of cerebral small vessel
disease and spontaneous ICH, to enhance diagno-
sis, prevention and treatment.
Perivascular spaces (also known as Virchow–
Robin spaces) are interstitial ﬂuid-ﬁlled3 cavities
surrounding the small penetrating vessels which
function as the brain drainage system,4 and have
been recognised pathologically for many years.
Enlarged perivascular spaces (EPVS) can also be
seen on MRI, and have attracted attention as a
potential neuroimaging marker of small vessel
disease.5 6 Although EPVS are common ﬁnding in
the elderly,7 8 and show consistent associations
with other markers of small vessel damage,6 they
have received relatively little attention to date,
usually being considered unimportant or even
normal. EPVS are visible on T2-weighted cerebral
MRI as characteristically small, high-signal areas in
the basal ganglia and centrum semiovale.6
ICH is perhaps the most devastating clinical con-
sequence of small vessel disease, yet EPVS have not
been systematically studied in this population.
There is an urgent need to develop more sensitive
diagnostic markers of the arteriopathies underlying
ICH, particularly CAA.2 In the present study, our
aims were to determine the prevalence, distribution
and severity of EPVS in ICH, and investigate their
associations with other imaging markers of small
vessel disease, and with presumed ICH aetiology.
We hypothesised that, in patients with ICH:
(1) EPVS are common; (2) EPVS severity is asso-
ciated with other small vessel disease MRI markers
including white-matter changes, lacunes and cere-
bral microbleeds (CMBs) and (3) patients with
strictly lobar ICH attributed to CAA have a higher
prevalence of severe EPVS in the centrum semio-
vale compared with other ICH, due to the
expected distributions of the underlying
arteriopathies.
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PATIENTS AND METHODS
Study participants and data collection
We performed a retrospective analysis of patients with spontan-
eous ICH (deﬁned as ICH without evidence for an underlying
cause, except for sporadic small vessel disease) referred to four
specialist stroke centres over deﬁned time periods in the UK and
Belgium. The hospitals were: University College London
Hospitals National Health Servie (NHS) Foundation Trust (09/
2004–06/2011), Cliniques Universitaires Saint Luc (Brussels)
(12/2004–04/2008), CHU Mont-Godinne UCL (Belgium) (08/
2005–06/2008) and Addenbrooke’s Hospital (Cambridge) (07/
2002–12/2009). At all participating centres, MRI scanning is a
routine investigation for ICH, unless there are contraindications.
Cases were systematically ascertained using multiple overlapping
methods from prospective clinical databases and radiological
reports. A total of 377 patients with ICH were screened, of
whom 129 were excluded because of diagnosis of non-
spontaneous ICH (eg, secondary to aneurysms, tumours, caver-
nomas, etc), and 127 because MRI with the necessary sequences
of adequate quality was not available for analysis.
We categorised cases of spontaneous ICH as either strictly lobar,
consistent with a diagnosis of CAA (clinically possible or probable
CAA according to the Boston criteria9) or ‘other ICH’ (ie, deep
ICH and mixed deep and lobar ICH). Demographic and clinical
information (eg, age at time of MRI, gender, vascular risk factors,
use of antithrombotics, etc) was obtained from prospective data-
bases and by medical records review using standardised data col-
lection forms. Hypertension was deﬁned as a history of
hypertension, taking antihypertensive treatment or documented
elevated blood pressure (systolic >150 or diastolic >95 mmHg)
prior to ICH, diabetes as ongoing use of a hypoglycaemic agent,
and smoking as history of tobacco use before admission.
The study received ethical approval by the National Hospital
for Neurology and Neurosurgery and Institute of Neurology
Joint Research Ethics Committee, the Commission d’Ethique
Biomedicale Hospitalo Facultaire of the Faculte de Medicine
(Universite Catholique de Louvain), and the Comite d’ethique
medicale of the Cliniques Universitaires UCL de Mont
Godinne.
MRI acquisition and analysis
The MRI stroke protocol was similar in each hospital. Imaging
was at 1.5 T ﬁeld strength and included axial T1-weighted,
T2-weighted, coronal ﬂuid-attenuated inversion recovery
(FLAIR), axial diffusion-weighed imaging and T2*-weighted
gradient-recalled echo (T2*-GRE) sequences (see online supple-
mentary table S1).
MRI were reviewed on medical imaging workstations, blinded
to clinical details. The presence, number and distribution (lobar-
including cerebellum, as suggested in the Boston criteria9 and
deep-including brainstem) of ICHs were recorded. The pres-
ence, number and distribution of CMBs were evaluated on
T2*-GRE images using the Microbleed Anatomical Rating
Scale.10 White-matter changes were rated on a four-point scale
(0–3)11 on coronal FLAIR, T1-weighted and T2-weighted MRI.
EPVS were rated on axial T2-weighted MRI by a trained
observer, using a validated visual rating scale.6 12 EPVS were
deﬁned as small, sharply delineated structures of Cerebrospinal
Fluid (CSF) intensity (or close to CSF intensity), measuring
<3 mm following the course of perforating or medullary vessels
(ﬁgure 1). Lacunes were distinguished from EPVS by their
larger size (>3 mm), spheroid shape and surrounding hyperin-
tensity on FLAIR. EPVS were rated in basal ganglia and
centrum semiovale regions. For both of these anatomical areas,
the EPVS rating categories applied were: 0=no EPVS, 1≤ 10
EPVS, 2=11–20 EPVS, 3=21–40 EPVS and 4≥40 EPVS. The
numbers refer to EPVS on one side of the brain: after reviewing
all relevant slices for the anatomical area being assessed, the
slice and side with the highest number of EPVS was
recorded.6 12 In patients with other ICH, basal ganglia EPVS
were evaluated contralateral to the lesion if deep ICH was
present. The assessment of EPVS may have been inﬂuenced by
the presence of conﬂuent white-matter changes; in such cases,
as per guidance provided for the rating scale we used,6 estima-
tion was made of the closest EPVS rating category, using the
appearance of non-involved white matter, and cortical grey
matter. Similarly, in cases of large lobar ICH, centrum semiovale
EPVS were assessed contralateral to the index ICH lesion; an
estimation of the closest centrum semiovale EPVS rating cat-
egory ipsilateral to the lesion was made, and the highest number
of EPVS was recorded. Intrarater reliability testing (n=30 scans)
showed an excellent intrarater Cohen’s kappa value of 0.91 for
basal ganglia EPVS and 0.82 for centrum semiovale EPVS.
Statistical analysis
We compared clinical and imaging characteristics of patients
with strictly lobar ICH (attributed to CAA according to the
Boston criteria) to those with other ICH, using χ2 tests and the
Fisher’s exact test for categorical variables, and two-sample
t tests or Mann–Whitney U tests depending on the distribution
of continuous variables. To test our hypothesis, we sought to
compare the prevalence of severe centrum semiovale and basal
ganglia EPVS (>40 EPVS) in the two ICH groups. However,
since only one patient had severe basal ganglia EPVS in a posthoc
Figure 1 Axial T2-weighted MRI. (A and B) Dot-like hyperintensities
characteristic of enlarged perivascular spaces (EPVS) in the basal
ganglia in a patient with spontaneous deep intracerebral haemorrhage
(ICH). (C and D) Linear hyperintensities typical of EPVS in the centrum
semiovale in a patient with cerebral amyloid angiopathy-related lobar
ICH. Note that deep brain regions (eg, basal ganglia) are not affected
by EPVS (D).
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analysis, we compared frequent-to-severe basal ganglia EPVS
(>20) in the two ICH groups. Both crude and age-adjusted
severe EPVS centrum semiovale prevalence rates are reported.
For the logistic regression analysis, severity of EPVS was trichoto-
mised due to the small number of patients with no EPVS or >40
EPVS (1 (mild; 1–10), 2 (moderate; 11–20) and 3 (severe; over
21)). Ordinal logistic regression analysis was used to identify pre-
dictors of increasing EPVS severity in the two anatomical areas
(centrum semiovale and basal ganglia) and for total brain EPVS.
Multivariable analysis was adjusted for age, lobar microbleeds,
deep microbleeds, white-matter changes score and lacunes, based
on the results of univariable analysis, plus other biologically
plausible confounders, especially neuroimaging markers of small
vessel disease. As a sensitivity analysis, we repeated these analyses
with the addition of other variables in our model (including sex,
hypertension, CAA-group etc). Using a likelihood ratio test, the
assumption of proportional odds for the ordinal logistic regres-
sion models was met. A p value ≤0.05 was considered to be stat-
istically signiﬁcant. All statistical analyses were carried out using
STATA data analysis and statistical software (V.11.2, StataCorp).
RESULTS
Patients with spontaneous ICH excluded from the study were not
signiﬁcantly different from those included in measures of ICH
severity including: median (IQR range) ICH volume (10.5 cm3;
2.93–18.81 cm3 vs 12.84 cm3; 4.05–25.31 cm3; p=0.288),
median (IQR range) Glasgow Coma Score on admission (14; 11–
15 vs 15; 14–15; p=0.087) in patients excluded versus patients
included, respectively. Patients excluded had a higher prevalence
of deep ICH (50.5% vs 27.4%, p=0.005). The ﬁnal cohort con-
sisted of 121 patients with ICH (mean age 69.4 (95% CI 67.2 to
69.6); 69 (57%) male); 76 (63%) had strictly lobar ICH, fulﬁll-
ing the Boston criteria for probable (n=53) or possible (n=23).
The clinical and radiological characteristics of the ICH cohort
overall, and according to ICH location, are reported in table 1.
The median time from ICH to MRI was 10 days (IQR:
3–61 days).
Prevalence and distribution of EPVS in ICH
Almost all patients had some degree of EPVS (table 1); the
mean total score was 4.38 (95% CI 4.18 to 4.58).
Patients with strictly lobar ICH had a signiﬁcantly higher
prevalence of severe EPVS (>40 EPVS) in the centrum semio-
vale compared with other ICH patients (35.5% vs 17.8%,
respectively; p=0.041) (table 1) The age-adjusted prevalences of
severe EPVS in the centrum semiovale are 29.3% (95% CI
23.1% to 35.5%) in the strictly lobar ICH group versus 13.5%
(95% CI 9.3% to 17.8%) in the ‘other ICH’ group (p<0.05)
(ﬁgure 2).
It was not possible to test for differences between the strictly
lobar and other ICH groups in the prevalence of severe basal
ganglia EPVS since only one patient had severe basal ganglia
Table 1 Patient characteristics
n (%) Overall (n=121) Strictly lobar ICH (n=76) Other ICH (n=45) p Value
Age, mean (95% CI), years 69.4 (67.2 to 69.6) 71.1 (68.4 to 73.8) 66.6 (62.8 to 72.4) 0.05
Sex, male 69 (57) 41 (54) 28 (62.2) 0.449
History of hypertension 86 (72.9) 49 (67.1) 37 (82.2) 0.090
Smoking history 39 (33.3) 22 (30.1) 17 (38.6) 0.419
Diabetes 20 (17.1) 11 (15.1) 9 (20.5) 0.459
On statins 26 (22) 15 (20.6) 11 (25) 0.648
On antithrombotics 38 (32.8) 27 (37) 11 (25.6) 0.226
First-ever ICH 68 (63) 40 (62.5) 28 (63.6) 1.000
Lacunar infarct 25 (49) 11 (37.9) 14 (63.6) 0.093
Multiple ICHs 47 (39.8) 34 (46.6) 13 (28.9) 0.081
Microbleeds presence 79 (67.5) 45 (62.5) 34 (75.6) 0.160
Microbleeds type
Lobar 77 (64.7) 45 (62.5) 30 (68.2) 0.556
Deep 28 (23.1) 0 28 (63.6) <0.0001
Mean total white matter changes score (95% CI) 8.58 (7.59 to 9.57) 8.21 (6.95 to 9.46) 9.18 (7.53 to 10.83) 0.346
Mean total EPVS score (95% CI) 4.38 (4.18 to 4.58) 4.29 (4.04 to 4.54) 4.53 (4.17 to 4.9) 0.255
Mean basal ganglia EPVS score (95% CI) 1.50 (1.37 to 1.63) 1.32 (1.18 to 1.45) 1.8 (1.56 to 2.05) 0.0003
Mean centrum semiovale EPVS score (95% CI) 2.85 (2.72 to 3.05) 2.97 (2.76 to 3.19) 2.73 (2.47 to 2.99) 0.1590
EPVS centrum semiovale
Mild: 1–10 7 (5.8) 4 (5.3) 3 (6.7) 0.338*
Moderate: 11–20 36 (29.8) 21 (27.6) 15 (33.3)
Frequent: 21–40 43 (35.5) 24 (31.6) 18 (40)
Severe: >40 35 (28.9) 27 (35.5)† 8 (17.8)†
EPVS basal ganglia
No EPVS 2 (1.7) 2 (2.6) 0 (0) 0.005*
Mild: 1–10 70 (57.9) 51 (67.1) 19 (42.2)
Moderate: 11–20 37 (30.6) 20 (26.3) 17 (37.8)
Frequent: 21–40 11 (9.1) 3 (4) 8 (17.8)
Severe: >40 1 (0.8) 0 (0) 1 (2.2)
p Values refer to differences between strictly lobar (clinically probable or possible CAA) and other ICH.
*p Value for trend across groups.
†Statistically significant difference between strictly lobar (possible or probable CAA) and other ICH (see figure 2 for age-adjusted prevalences).
CAA, cerebral amyloid angiopathy; EPVS, enlarged perivascular spaces; ICH, intracerebral haemorrhage.
626 Charidimou A, et al. J Neurol Neurosurg Psychiatry 2013;84:624–629. doi:10.1136/jnnp-2012-304434
Cerebrovascular disease
 group.bmj.com on July 21, 2014 - Published by jnnp.bmj.comDownloaded from 
EPVS. However, in a posthoc analysis, the proportion of patients
with frequent-to-severe basal ganglia EPVS (>20) was higher in
those with other ICH than in strictly lobar ICH (20% vs 4%,
p=0.009).
There was no statistically signiﬁcant relationship between basal
ganglia and centrum semiovale EPVS severity (compared using χ2
test across categories; see online supplementary table S2). For
factors associated with increasing severity of total EPVS, see online
supplementary table S3 and online supplementary ﬁgure S1.
Predictors of increased EPVS severity in logistic regression
In univariable ordinal logistic regression analysis, signiﬁcant pre-
dictors of increasing EPVS severity in the basal ganglia were
age, smoking history, the presence of CMBs, presence of deep
CMBs, presence of lacunes, mean white-matter changes score
and other ICH (non-CAA aetiology) (table 2). In multivariable
logistic regression analysis (table 3), age (OR: 1.43, per 10 years
increase; 95% CI 1.01 to 2.02; p=0.045), presence of deep
CMBs (OR: 3.27; 95% CI 1.27 to 8.45; p=0.014), and mean
white-matter changes score (OR: 1.29, per unit increase; 95%
CI 1.17 to 1.43; p<0.0001) were independent predictors of
increased basal ganglia EPVS severity, after adjusting for the
presence of lobar CMBs and lacunes.
No clinical or radiological variables were found to be signiﬁ-
cantly associated with increasing EPVS severity in the centrum
semiovale, at the 5% level, in univariable analysis; age was mar-
ginally signiﬁcant. In multivariable analysis, age was the only sig-
niﬁcant independent predictor of increasing EPVS severity in
the centrum semiovale: for every 10 years increase in age, the
odds of having an increase in centrum semiovale EPVS was 1.50
(95% CI 1.08 to 2.10; p=0.017).
Logistic regression analyses of total EPVS severity are shown
in online supplementary tables S3 and S4.
DISCUSSION
In this multicentre retrospective study, we found that the distri-
bution of severe EPVS differed according to the location of
ICH: severe centrum semiovale EPVS were twice as common in
patients with strictly lobar (ie, probable or possible CAA) than
in those with other ICH. By contrast, the ICH patients not ful-
ﬁlling these criteria for CAA more often had frequent-to-severe
basal ganglia EPVS compared with strictly lobar ICH patients.
In the whole cohort, we found that age, white-matter changes
and deep CMBs were independently associated with basal
ganglia EPVS severity, but only age was independently associated
with increased centrum semiovale EPVS severity. Our study thus
Table 2 Univariable (unadjusted) ordinal logistic regression analysis showing predictors of increased basal ganglia and centrum semiovale
EPVS severity in the whole cohort
Basal ganglia EPVS Centrum semiovale EPVS
(Yes vs No) OR (95% CI) p Value OR (95% CI) p Value
Age (per 10 years older) 1.41 (1.02 to 1.95) 0.036 1.36 (0.98 to 1.87) 0.065
Sex, male 0.53 (0.26 to 1.10) 0.088 0.56 (0.27 to 1.18) 0.128
History of hypertension 1.05 (0.57 to 2.33) 0.469 0.68 (0.28 to 1.63) 0.381
Smoking history 2.89 (1.35 to 6.18) 0.006 1.20 (0.53 to 2.71) 0.666
Diabetes 1.26 (050 to 3.16) 0.622 1.11 (0.39 to 3.13) 0.851
On statins 0.71 (0.29 to 1.72) 0.441 0.74 (0.31 to 1.81) 0.514
On antithrombotics 0.62 (0.28 to 1.38) 0.240 0.70 (0.31 to 1.57) 0.387
First ever ICH 0.64 (0.30 to 1.37) 0.248 1.07 (0.47 to 2.46) 0.866
Other ICH (non-CAA aetiology) 3.58 (1.70 to 7.54) 0.001 0.74 (0.35 to 1.57) 0.431
Lacunar infarct 2.75 (0.93 to 8.14) 0.068 2.84 (0.87 to 9.29) 0.083
Multiple ICHs 0.71 (0.34 to 1.47) 0.350 0.87 (0.41 to 1.86) 0.724
Microbleeds presence 2.29 (1.01 to 5.21) 0.048 1.62 (0.73 to 3.56) 0.233
Strictly lobar microbleeds 0.99 (0.48 to 2.04) 0.985 1.59 (0.73 to 3.47) 0.246
Lobar microbleeds 1.81 (0.82 to 3.99) 0.140 1.89 (0.87 to 4.13) 0.109
Deep microbleeds 2.25 (1.01 to 4.98) 0.046 0.97 (0.41 to 2.26) 0.937
Mean total white-matter changes score (for each unit increase) 1.23 (1.13 to 1.33) <0.0001 1.01 (0.94 to 1.08) 0.772
CAA, cerebral amyloid angiopathy; EPVS, enlarged perivascular spaces; ICH, intracerebral haemorrhage.
Table 3 Multivariable (adjusted) ordinal logistic regression analysis showing predictors of increased basal ganglia and centrum semiovale
EPVS severity in the whole cohort
Basal ganglia EPVS Centrum semiovale EPVS
OR (95% CI) p Value OR (95% CI) p Value
Age (per 10 years older) 1.43 (1.01 to 2.02) 0.045 1.50 (1.08 to 2.10) 0.017
Lobar microbleeds 0.43 (0.16 to 1.20) 0.107 1.92 (0.74 to 4.96) 0.180
Deep microbleeds 3.27 (1.27 to 8.45) 0.014 0.91 (0.35 to 2.38) 0.850
Mean total white-matter changes score (for each unit increase) 1.29 (1.17 to 1.43) <0.0001 0.99 (0.91 to 1.08) 0.856
Lacunar infarct 1.00 (1.00 to 1.01) 0.362 1.00 (0.99 to 1.00) 0.918
EPVS, enlarged perivascular spaces.
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provides new evidence that the distribution of severe EPVS
reﬂects the underlying arteriopathy type in spontaneous ICH.
We found EPVS in almost every participant in our study, and
moderate to severe centrum semiovale and basal ganglia EPVS in
more than 90% and 40% of them, respectively. To our knowl-
edge, no previous imaging study has investigated the prevalence
and distribution of EPVS in spontaneous ICH. A recent prospect-
ive study which evaluated EPVS in patients with acute lacunar
stroke (n=129), cortical stroke (n=124) and age-matched non-
stroke controls (n=97), found that EPVS were more prevalent in
small vessel (lacunar) ischemic stroke than large vessel stroke.6 In
this study, Doubal and colleagues6 used the same EPVS rating
scale, applied to T2-weighted MR images, as in our study, thus
allowing comparisons to be made. The mean total EPVS score in
our ICH cohort (4.38, 95% CI 4.18 to 4.58) is close to that of
patients with lacunar stroke (3.81, SD: 1.76), but higher than
non-stroke controls (1.02, SD: 0.89).6 However, the absence of a
non-ICH control group in our study makes it difﬁcult to directly
compare EPVS counts with other patient groups.
Although EPVS have not been studied in ICH cohorts, previ-
ous pathological and neuroimaging studies in other patient
populations have shown a signiﬁcant association between hyper-
tension, white-matter changes, and EPVS.13 14 The associations
we found between the severity of basal ganglia and total EPVS
with the severity of white-matter changes further add to evi-
dence that EPVS are an imaging manifestation of cerebral small
vessel disease rather than an incidental ﬁnding. The association
of EPVS with white-matter changes seems consistent across dif-
ferent populations including vascular dementia,15 Alzheimer’s
disease and mild cognitive impairment. A large population-
based study also reported an association between the degree of
EPVS and the volume of white-matter changes, as well as with
the prevalence of lacunes.16
We also found that EPVS associations vary according to their
distribution (table 3), suggesting different pathophysiological
mechanisms relevant to the underlying arteriopathy in ICH.
Basal ganglia EPVS were independently associated with age,
white-matter changes burden and deep CMBs, suggesting hyper-
tensive arteriopathy as a possible underlying mechanism. It is
likely that at least some white-matter changes share a common
pathophysiological mechanism with EPVS, perhaps related to
blood-brain barrier disruption, a potentially key pathogenic
process in cerebral small vessel disease.5 Indeed, it has been sug-
gested that white-matter changes tend to form around EPVS,5
and that EPVS may be an early imaging marker of small vessel
disease and blood-brain barrier alteration. By contrast, in the
present study, EPVS in the centrum semiovale were only asso-
ciated with age, and not with other imaging or clinical factors.
In the study by Doubal et al6 in patients with minor ischaemic
stroke, total EPVS were also associated with white-matter
changes after adjusting for age, the presence of stroke and vascu-
lar risk factors (p<0.001); centrum semiovale EPVS were not
associated with any explanatory variables, in keeping with our
ﬁndings.6 It is thus possible that a distinct pathophysiological
process other than hypertensive arteriopathy contributes to the
development of centrum semiovale EPVS: CAA is a likely candi-
date, a hypothesis consistent with evidence that advancing age is
the strongest clinical risk factor for sporadic CAA.2 Although
we did not ﬁnd a signiﬁcant association between EPVS severity
in the centrum semiovale and the presence of lobar microbleeds
(a putative neuroimaging marker of CAA) at the 5% level, the
OR suggests a possible effect (OR: 1.92; 95% CI 0.74 to 4.96;
table 3); our ability to detect any association may be limited by
our sample size and the high prevalence of hypertension, which
can also contribute to lobar CMBs. In addition, the absence of
association between basal ganglia and centrum semiovale EPVS
severity (see online supplementary table S2) further supports
the notion that EPVS in these two anatomical compartments are
related to different pathophysiological processes.
Severe EPVS in our ICH cohort showed a different anatom-
ical pattern depending on the location and the presumed small
vessel arteriopathy underlying ICH. In patients with strictly
lobar, presumed CAA-related ICH, the centrum semiovale was
more often affected by severe EPVS compared with other ICH
patients (ﬁgure 2). A predilection of severe EPVS for the
centrum semiovale most parallels the topography of CAA path-
ology, since amyloid-β is deposited primarily in cortical and
leptomeningeal small vessels, largely sparing small vessels in the
basal ganglia.2 Moreover, several lines of evidence suggest that
perivascular spaces have a key role in the pathophysiology of
CAA.2 It is hypothesised that an important mechanism under-
lying vascular amyloid-β deposition is impaired clearance of
amyloid-β along perivascular drainage pathways.2 As amyloid-β
is deposited in the walls of small arteries, it could block perivas-
cular drainage, leading to dilation of perivascular spaces down-
stream in the underlying deep white matter, even in regions not
directly affected by CAA pathology. This regional preference for
severe EPVS further supports our hypothesis that severe
centrum semiovale EPVS are at least partly related to CAA,
whereas, basal ganglia EPVS are most likely related to hyperten-
sive arteriopathy affecting deep perforators. Severe centrum
semiovale EPVS may, therefore, be a potential useful new neu-
roimaging marker of CAA, in an appropriate clinical context.
The diagnosis of CAA currently depends on the radiological
demonstration of multiple strictly lobar haemorrhages; existing
criteria have high speciﬁcity but limited sensitivity.9 17 Whether
severe EPVS presence and topography might usefully improve
the sensitivity for current diagnostic criteria for CAA9 requires
further study with pathological veriﬁcation of CAA.
Our multicentre study has several strengths including the sys-
tematic evaluation of MRI scans by trained raters using vali-
dated scales for a range of imaging markers of small vessel
disease, and the use of a validated EPVS rating scale.6 A poten-
tial limitation is the lack of pathological conﬁrmation of the
CAA pathology as a cause of ICH, in view of the imperfect
Figure 2 Age-adjusted prevalence of severe centrum semiovale
enlarged perivascular spaces (EPVS) (>40 EPVS) in patients with strictly
lobar intracerebral haemorrhage (ICH), attributed to cerebral amyloid
angiopathy, compared with other ICH. Age was used as a continuous
variable. (For within-group comparisons of the proportion of patients
with centrum semiovale EPVS vs basal ganglia EPVS for lobar ICH and
other ICH see online supplementary material).
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sensitivity and speciﬁcity of the Boston criteria (particularly
their overall sensitivity and the speciﬁcity of the ‘possible CAA’
category).9 We may thus have misclassiﬁed some patients as
CAA-related ICH when their ICH was related to hypertensive
arteriopathy. It is also likely that some of the patients with
‘other ICH’ (eg, spontaneous deep ICH), many of whom had
lobar CMBs, not classiﬁed as CAA related might in fact have
some degree of CAA pathology as well as hypertensive arterio-
pathy. However, any misclassiﬁcation of patients would tend to
bias toward a null result (no between-group differences in EPVS
severity or distribution), suggesting that EPVS may in fact be a
more powerful marker for CAA than we have been able to dem-
onstrate here. It was not possible to blind the EPVS rater to
ICH location, potentially introducing a bias towards the study
hypothesis. We also acknowledge the potential of bias in our
sample, as MRIs were done as part of routine clinical care, and
many patients were excluded from this analysis because of inad-
equate MRI data. Finally, due to the retrospective and cross-
sectional nature of our study we were not able to determine the
prognostic signiﬁcance of EPVS in this cohort.
In summary, we found that EPVS are present in almost all
patients with spontaneous ICH, but with evidence for different
underlying mechanisms according to their distribution. Basal
ganglia EPVS severity is associated with markers of hypertensive
arteriopathy including white-matter changes and deep CMBs,
while centrum semiovale EPVS are associated with age and are
more often severe in patients with strictly lobar ICH attributed
to CAA. A predilection of severe EPVS for the centrum semio-
vale rather than the basal ganglia may, therefore, be secondary
to, and indicative of, CAA. Further studies with pathological
veriﬁcation are needed to determine the relevance of EPVS for
improving the sensitivity of CAA diagnostic criteria.
Longitudinal studies are required to explore whether EPVS are
an early feature of the small vessel disease underlying ICH,
their change over time, and prognostic implications for clinical
outcome.12 18
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